Clinical Trials Directory

Trials / Unknown

UnknownNCT01204554

Microcirculation in Perforator Flaps. Enhancing Tissue Survival

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Detailed description

Perforator flaps are increasingly used in reconstructive surgery both as pedicled and free flaps, mostly because of reduced donor site morbidity and superior aesthetic result. However, the there is still much to learn about the hemodynamic changes within these flaps.The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Conditions

Interventions

TypeNameDescription
DRUGIndocyanine green (ICG)a water-soluble dye that binds to plasma proteins and remains in the intravascular space after intravenous injection.ICG has a normal plasma half life of 3-4 min. Dosage planned is 0 .5 mg/kg dose of ICG resolved in 5 % dextrose 2 mg /ml.

Timeline

Start date
2008-09-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-09-17
Last updated
2010-09-17

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01204554. Inclusion in this directory is not an endorsement.